Osteologix Inc. (OTCBB:OLGX) today announced that Philip J. Young, President and CEO of Osteologix, will present a corporate overview on Monday, May 19 at 9:00 a.m. CEST (3:00 a.m. ET) during the Rodman and Renshaw 5th Annual Global Healthcare Conference at Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. A live audio webcast and slide presentation will be available via the internet by visiting www.osteologix.com and clicking the link provided under â€œLatest Newsâ€. An archived presentation will be available for 90 days.
Osteologix is a specialty biopharmaceutical company committed to improving the health of those afflicted with musculoskeletal diseases, such as osteoporosis, by developing innovative therapies. Its lead investigational product candidate, NB S101, is a novel pharmaceutical agent for the treatment and prevention of osteoporosis. For more information please visit www.osteologix.com.
Investor and Media:
Baxter Phillips, III
Sr. Director, Corporate Development